International Clinical Trial: Bupivacaine Liposome Suspension Administration to Decreasre Peri-procedural Pain in Interventional Radiology (IR) Procedures

Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07535411) titled 'Bupivacaine Liposome Suspension Administration to Decreasre Peri-procedural Pain in Interventional Radiology (IR) Procedures' on April 10.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Massachusetts General Hospital

Condition: Analgesia Assessment

Intervention: Drug: Liposomal Bupivacaine (EXPAREL(R))/Bupivacaine

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: May 2026

Target Sample Size: 10

To know more, visit https://clinicaltrials.gov/study/NC...